APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD).
| Author | |
|---|---|
| Abstract |
:
Inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia is an adult-onset autosomal dominant illness (IBMPFD) caused by mutations in the valosin-containing protein (VCP) on chromosome 9p21.1-p12. The penetrance of the gene is 82% for myopathy, 49% for Paget's disease, but may be as low as 30% for frontotemporal dementia. Modifier genes could account for decreased frontotemporal dementia penetrance. In this study apolipoprotein-E (APOE) was evaluated for this role in IBMPFD families based on its known modifier effect in Alzheimer's disease. |
| Year of Publication |
:
2007
|
| Journal |
:
Genetics in medicine : official journal of the American College of Medical Genetics
|
| Volume |
:
9
|
| Issue |
:
1
|
| Number of Pages |
:
9-13
|
| ISSN Number |
:
1098-3600
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/00125817-200701000-00003
|
| DOI |
:
10.1097/gim.0b013e31802d830d
|
| Short Title |
:
Genet Med
|
| Download citation |